<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the association between serum gamma-glutamyltransferase (GGT) and risk of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Japanese male office workers </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: This study included 2,957 metabolic syndrome-free men and 3,260 nondiabetic men aged 35-59 years who did not have medication for <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, alanine aminotransferase (ALT) levels higher than three times the upper limit of the reference range, or a history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> at study entry </plain></SENT>
<SENT sid="2" pm="."><plain>Subjects were reexamined at periodic annual health examinations over a 7-year period </plain></SENT>
<SENT sid="3" pm="."><plain>We used a modified National Cholesterol Education Program definition of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> with BMI instead of waist circumference and the revised criteria of the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: With adjustment for age, family history of <z:mp ids='MP_0002055'>diabetes</z:mp>, BMI, alcohol intake, cigarette smoking, regular physical activity (fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> for the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>), and white blood cell (WBC) count, the risk of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increased in correlation with the levels of serum GGT, ALT, <z:chebi fb="0" ids="29995">aspartate</z:chebi> aminotransferase (AST), and alkaline phosphatase </plain></SENT>
<SENT sid="5" pm="."><plain>Additional adjustment for <z:hpo ids='HP_0000001'>all</z:hpo> of the other liver enzymes attenuated these associations, but serum GGT remained a significant risk factor for the risk of both <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (P for trend &lt;0.001 for both) </plain></SENT>
<SENT sid="6" pm="."><plain>Top one-fifth versus bottom one-fifth relative risks of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were 2.23 (95% CI 1.51-3.30) and 2.44 (1.34-4.46), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results indicate that serum GGT may be an important predictor for developing <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in middle-aged Japanese men </plain></SENT>
</text></document>